By Steven Greer, MD
The CardioMEMS’ heart failure pressure measurement system will be evaluated by an FDA advisory committee next month. The CHAMPION trial, led by Dr. Abraham at Ohio State, demonstrated that the constant pressure monitor implanted in the pulmonary artery can reduce hospitalization rates for congestive heart failure patients, increasing quality of life and decreasing cost.
The device is powered by energy sources outside the body and has no moving parts. Therefore, the device does not need to be replaced and has a low chance of fracturing or causing bodily harm once implanted.